5 completed, 2 terminated. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 5, Terminated 2 |
| Phase 2 | 1 | Completed 1 |
Follow isavuconazole: new trials by email Literature Review of isavuconazole trials Research Report on isavuconazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Azole-echinocandin Combination Therapy for Invasive Aspergillosis Azole, Anidulafungin - Invasive Aspergillosis | Phase 3 | Terminated | Erasmus Medical Center | 66 | 2021-05-11 | 2024-05-07 |
| Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis Isavuconazonium Injection [Cresemba], Placebo - Severe Acute Respiratory Syndrome Coronavirus 2, Aspergillosis Invasive | Phase 3 | Terminated | Jeffrey Jenks, MD, MPH | 8 | 2021-03-16 | 2022-11-25 |
| Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis AK1820, Voriconazole - Deep Mycosis | Phase 3 | Completed | Asahi Kasei Therapeutics Corporation | 103 | 2018-04-16 | 2021-05-14 |
| Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi isavuconazole - Aspergillosis, Invasive Fungal Infections | Phase 3 | Completed | Astellas Pharma Inc | 149 | 2008-04-22 | 2024-12-11 |
| Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections Isavuconazole, Caspofungin, Voriconazole - Candidiasis, Invasive, Candidemia | Phase 3 | Completed | Astellas Pharma Inc | 450 | 2007-03-08 | 2024-12-10 |
| Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis Isavuconazole, Voriconazole - Aspergillosis, Invasive Fungal Infection | Phase 3 | Completed | Astellas Pharma Inc | 527 | 2007-03-07 | 2024-12-10 |
| Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy Isavuconazole - Acute Myeloid Leukemia | Phase 2 / Phase 3 | Completed | Basilea Pharmaceutica | 18 | 2006-05-01 | 2023-05-10 |
Aspergillosis (3) · Invasive Fungal Infections (2) · Candidemia (1) · Candidiasis, Invasive (1) · Cryptococcosis (1) · Leukemia, Myeloid, Acute (1) · Mucormycosis (1) · Mycoses (1)
Astellas Pharma Inc (3) · Asahi Kasei Therapeutics Corporation (1) · Basilea Pharmaceutica (1) · Erasmus Medical Center (1) · Jeffrey Jenks, MD, MPH (1)
Belgium (4) · Germany (4) · United States (4) · Argentina (3) · Australia (3) · Brazil (3) · Canada (3) · Chile (3) · France (3) · India (3) · Israel (3) · Mexico (3) · Russia (3) · Thailand (3) · China (2)
Bart Rijnders, MD, PhD (1) · George Thompson, MD (1) · Jeffrey Jenks, MD, MPH (1) · Martin Hoenigl, MD (1) · Oliver Cornely, MD (1)
PMID 37185921, PMID 25624327, PMID 25902926, PMID 26684607, PMID 26969258, PMID 27169478, PMID 27185799, PMID 28472247, PMID 30289478, PMID 35191210, PMID 36307059, PMID 38419156, PMID 39378343
2005 (1)